Maryland Department Of Health

The Maryland Department of Health Prevention & Health Promotion Administration – Ideha Division (operating as Prevention & Health Promotion Administration – Ideha) is a U.S. state government entity and a child division of the State of Maryland that receives federal grants and enters into federal contracts as a prime recipient in public health and food safety domains, with no subcontract footprint of significance.

Ideha operates as a public health regulator and service delivery organization, receiving federal cooperative agreements and project grants for food safety testing and inspection, infectious disease surveillance and laboratory capacity, behavioral health crisis response and suicide prevention, opioid response and treatment coordination, immunization programs, and environmental health tracking. The organization holds no parent contract vehicles and does not compete for work through federal procurement set-asides; all work flows through direct federal agency grants and contracts with FDA, CDC, SAMHSA, CMS, and other HHS components. The combined potential value across Ideha's 133 prime and sub awards stands at $8.4 million, though obligated dollars total $2.08 billion, reflecting a high ratio of invoiced performance relative to stated ceiling values on cooperative agreements.

Ideha's customer concentration runs heavily toward Department of Health and Human Services components. The Food and Drug Administration leads by potential value (14 awards, $6.6 million combined), anchored by a $1.63 million definitive contract for human food Maryland state inspections (awarded September 30, 2026, through September 29, 2031) and a $571 thousand contract for human food inspections in Baltimore (awarded September 12, 2023, through September 29, 2026). The Centers for Disease Control and Prevention dominates by award count (36 awards), funding immunization surveillance and vaccine distribution, emerging infectious disease laboratory capacity, violent death reporting systems, environmental public health tracking, and workforce development for state and local public health infrastructure. SAMHSA operates a substantial behavioral health and opioid response grant portfolio including the $735 thousand Maryland Connected Communities Initiative for youth suicide prevention (awarded September 30, 2026, through September 29, 2031), a $9.7 million 988 crisis line capacity grant (awarded September 30, 2023), and multiple opioid response and substance use disorder treatment grants. CMS funded a $12 million all-payer health equity cooperative agreement (awarded July 1, 2024, through December 31, 2029).

Recent activity shows a declining trend: nine awards in 2022, seven in 2023, eight in 2024, four in 2025, and two in 2026 (year to date). Sixteen awards face ultimate completion within the next twenty-four months, representing recompete exposure for Ideha and opportunity for competitors. Ideha holds five sub-award relationships, all as a recipient under prime grants held by the Maryland Department of Transportation (three awards for child safety seats) and The Association of State and Territorial Health Officials (two awards for lead poisoning prevention activities).

Ideha's capability footprint centers on FDA-aligned food safety testing and regulatory oversight, CDC-aligned disease surveillance and laboratory infrastructure, behavioral health crisis response systems, and opioid use disorder prevention and treatment coordination delivered across Maryland's state and local health jurisdictions. Work is performed in Baltimore and Cape St Claire, Maryland, with statewide operational scope through 23 local health departments and Baltimore City. Ideha competes exclusively in full-and-open federal grant and contract vehicles with no set-aside designation; its sole customer base is federal health agencies that value state-level public health delivery capacity and established laboratory and surveillance infrastructure.